Caris Life Sciences Inc (CAI) Stock Price, Quote & News

Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions;...

Industry: Biotechnology

Sector: Healthcare

Phone: 866 771 8946

Fax: 866 479 4925

Website: www.carislifesciences.com

Address:

750 West John Carpenter Freeway, Suite 800, Irving, United States

jmash Jun. 5 at 4:12 AM

$CAI oh yeaaa

0 · Reply

amcjwilson Jun. 4 at 7:35 PM

$CAI + 15% !!!

0 · Reply

Damian23 Jun. 4 at 3:25 PM

$CAI Now we are talking, finally the attention it deserves. Price target 30$

1 · Reply

amcjwilson Jun. 4 at 2:43 PM

$CAI +10% day !!!

0 · Reply

jmash Jun. 4 at 2:28 PM

$CAI what a reversal

0 · Reply

Dietl Jun. 1 at 11:47 PM

$CAI Wolfe Research downgraded Caris to peer perform and removed the price target.

1 · Reply

PeterLynch_IsBack Jun. 1 at 10:57 PM

$CAI should I swap my dad NVO for Caris? I like the upside here.

0 · Reply

nancy19681027 Jun. 1 at 9:49 PM

$CAI Hi people, from the daily chart, you can see tem consolidated longer than cai. right now, tem has more momentum than cai. But longer time, I like more cai then tem. under comparason, cai is a better buy at current price.

0 · Reply

appayip Jun. 1 at 6:19 PM

$CAI why it is red, while $TEM is green. they always moved parallel. TEM is burning cash, while CAI is almost profitable. I still think i played on the right horse:)

1 · Reply

PeterLynch_IsBack May. 29 at 7:53 AM

$CAI looks interesting did a deep dive with claude this is undervalued AF

1 · Reply

Caris Life Sciences Transcript: AGM 2026

2026-06-01T20:57:19.000Z - 4 days ago

Caris Life Sciences assumed with a Peer Perform at Wolfe Research

2026-06-01T20:23:59.000Z - 4 days ago

Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research

May 12, 2026, 1:00 PM EDT - 24 days ago

Caris Life Sciences Transcript: Bank of America Global Healthcare Conference 2026

2026-05-11T17:55:47.000Z - 25 days ago

Caris Life Sciences announces publication of study on measuring TMB using WES

2026-05-08T23:01:06.000Z - 4 weeks ago

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

2026-05-08T16:53:15.000Z - 4 weeks ago

Caris Life Sciences price target lowered to $22 from $28 at Baird

2026-05-08T13:03:25.000Z - 4 weeks ago

Caris Life Sciences price target lowered to $32 from $38 at BTIG

2026-05-08T12:26:11.000Z - 4 weeks ago

Caris Life Sciences price target lowered to $30 from $35 at JPMorgan

2026-05-08T11:34:07.000Z - 4 weeks ago

Caris Life Sciences price target lowered to $28 from $35 at Citi

2026-05-07T21:18:19.000Z - 4 weeks ago

Caris Life Sciences reports Q1 EPS 0c, consensus (2c)

2026-05-07T21:17:18.000Z - 4 weeks ago

Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Caris Life Sciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Caris Life Sciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Caris Life Sciences Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Caris Life Sciences Quarterly report: Q1 2026

2026-05-04T13:08:37.000Z - 4 weeks ago

Caris Life Sciences’ ChromoSeq receives MolDX approval

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

Caris Life Sciences Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

Caris Life Sciences Proxy statement: Proxy filing

2026-04-12T23:45:06.000Z - 7 weeks ago

Caris Life Sciences initiated with a Buy at Jefferies

2026-04-10T08:50:43.000Z - 2 months ago

Caris Life Sciences initiated with a Neutral at Piper Sandler

2026-04-06T12:22:20.000Z - 2 months ago

Caris Life Sciences price target lowered to $30 from $34 at Evercore ISI

2026-04-02T12:43:00.000Z - 2 months ago

Caris Life Sciences launches Caris ChromoSeq tumor profiling assay

2026-04-01T09:15:47.000Z - 2 months ago

Caris Life Sciences initiated with a Buy at Goldman Sachs

2026-03-31T22:05:52.000Z - 2 months ago

Caris Life Sciences announces finalized Achieve 1 Study results

2026-03-20T12:35:13.000Z - 2 months ago

Caris Life Sciences announces publication of study on GPSai algorithm

2026-03-16T12:40:47.000Z - 2 months ago

Caris Life Sciences introduces new Caris AI Insights

2026-03-13T11:05:42.000Z - 3 months ago

Caris Life Sciences price target lowered to $22 from $30 at Canaccord

Feb 26, 2026, 4:30 PM EST - 3 months ago

Caris Life Sciences Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 3 months ago

Caris Life Sciences Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 3 months ago

Caris Life Sciences Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 3 months ago

Caris Life Sciences Slides: Q4 2025

Jan 12, 2026, 4:30 PM EST - 5 months ago

Caris Life Sciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 5 months ago

Caris Life Sciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 5, 2025, 4:30 PM EST - 7 months ago

Caris Life Sciences Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Caris Life Sciences Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Caris Life Sciences Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Caris Life Sciences Slides: Q3 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Caris Life Sciences Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Caris Life Sciences Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Caris Life Sciences Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Caris Life Sciences Slides: Q2 2025

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Caris Life Sciences Registration statement: Registration Filing

Jun 9, 2025, 8:00 AM EDT - 1 year ago

Caris Life Sciences Registration statement: Registration Filing

May 23, 2025, 5:54 PM EDT - 1 year ago

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

May 23, 2025, 5:12 PM EDT - 1 year ago

Caris Life Sciences discloses rise in revenue in US IPO filing

May 23, 2025, 4:22 PM EDT - 1 year ago

Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO

May 23, 2025, 3:27 PM EDT - 1 year ago

Caris Life Sciences IPO Registration Document (S-1)

jmash Jun. 5 at 4:12 AM

$CAI oh yeaaa

0 · Reply

amcjwilson Jun. 4 at 7:35 PM

$CAI + 15% !!!

0 · Reply

Damian23 Jun. 4 at 3:25 PM

$CAI Now we are talking, finally the attention it deserves. Price target 30$

1 · Reply

amcjwilson Jun. 4 at 2:43 PM

$CAI +10% day !!!

0 · Reply

jmash Jun. 4 at 2:28 PM

$CAI what a reversal

0 · Reply

Dietl Jun. 1 at 11:47 PM

$CAI Wolfe Research downgraded Caris to peer perform and removed the price target.

1 · Reply

PeterLynch_IsBack Jun. 1 at 10:57 PM

$CAI should I swap my dad NVO for Caris? I like the upside here.

0 · Reply

nancy19681027 Jun. 1 at 9:49 PM

0 · Reply

appayip Jun. 1 at 6:19 PM

$CAI why it is red, while $TEM is green. they always moved parallel. TEM is burning cash, while CAI is almost profitable. I still think i played on the right horse:)

1 · Reply

PeterLynch_IsBack May. 29 at 7:53 AM

$CAI looks interesting did a deep dive with claude this is undervalued AF

1 · Reply

jmash May. 29 at 12:52 AM

$CAI big volume today. This is moving

0 · Reply

Arcides May. 28 at 11:45 PM

$CAI The last breakdown has failed...

0 · Reply

Dietl May. 28 at 8:07 PM

$CAI a journey starts with a first step. Avg rec is $28.

0 · Reply

jmash May. 28 at 7:26 PM

$CAI heck yes

0 · Reply

drewboca May. 28 at 4:31 PM

$CAI starting to run an AI campaign to promote this stock Not investment advice but if you want to get rich buy like Drunkenmiller did.

0 · Reply

Dietl May. 27 at 8:18 PM

$CAI we are off here, or we sitting on amazing company that nobody knows about

1 · Reply

Katafrag May. 27 at 6:47 AM

$CAI Caris Life Sciences just launched a major patient campaign proving its ultra-deep AI genomic testing catches life-threatening misdiagnoses missed by rivals. This real-world survival data gives their newly expanded sales team massive leverage to win market share and unlock insurance coverage this quarter.

0 · Reply

Farorm May. 26 at 5:03 PM

$CAI started a position here, great value!

0 · Reply

appayip May. 25 at 7:35 AM

$CAI there is ASCO meeting in a week, it is important. we can hear some catalysts.

0 · Reply

Dietl May. 23 at 12:51 AM

$CAI we need to get over $20 first,

0 · Reply

appayip May. 22 at 6:41 PM

$CAI does anyone else think, this should be 50+ ? or am i too optimistic.

1 · Reply

Dietl May. 20 at 3:22 PM

$CAI I have bought more today, this hugely undervalued, vs $TEM and $GH, not aligned with the analysts, the market is algo the shares daily. Add 44% stock held by CEO alone and number of hedge funds, pretty weird float, looks like retail had abandoned the ship, where it got really cheap. Looking to $30 plus in 6 to 9 months

1 · Reply

Market Cap	4.38B
Revenue (ttm)	812.03M
Net Income (ttm)	-68.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	169.44
Profit Margin	-8.39%
Debt to Equity Ratio	0.64

Volume	2,740,800
Avg Vol	2,522,576
Day's Range	N/A - N/A
Shares Out	282.68M
Stochastic %K	47%
Beta	N/A
Analysts	Strong Sell
Price Target	$27.83